What are BTK Inhibitors and Why Are They Different? From the Spring 2023 Education Summit TheMSCenter 22:57 1 year ago 1 794 Скачать Далее
Failed Clinical Trial for BTK inhibitor?! WTH?! Aaron Boster MD 5:00 8 months ago 8 205 Скачать Далее
Non-covalent vs covalent BTK inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:23 2 years ago 707 Скачать Далее
BTK inhibitor associated cardiac arrhythmias VJHemOnc – Video Journal of Hematology & HemOnc 1:27 3 years ago 257 Скачать Далее
BTK inhibitor-associated adverse events in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 74 Скачать Далее
Choosing the best BTK inhibitor for managing CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:59 1 year ago 522 Скачать Далее
BTK inhibitors for MS treatment: what do the recent trial readouts mean for the field? VJNeurology 1:50 4 months ago 357 Скачать Далее
Reducing the side effects associated with BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:59 2 years ago 891 Скачать Далее
BTK inhibitors for CLL: acalabrutinib vs ibrutinib VJHemOnc – Video Journal of Hematology & HemOnc 3:11 2 years ago 2 395 Скачать Далее
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia VJHemOnc – Video Journal of Hematology & HemOnc 2:46 8 years ago 1 782 Скачать Далее
Second-generation BTK inhibitors and their clinical impact VJHemOnc – Video Journal of Hematology & HemOnc 2:57 2 years ago 233 Скачать Далее
Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 195 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 174 Скачать Далее
Updates on BTK inhibitor safety in multiple sclerosis VJNeurology 6:33 8 months ago 1 346 Скачать Далее
BTK and Immune Diseases | MOD Animation XVIVO Scientific Animation 2:11 2 years ago 5 285 Скачать Далее
BTK inhibition review in immune-mediated dermatological conditions Allergy 2:45 2 years ago 415 Скачать Далее
The value of BTK inhibitors in CLL & the future of acalabrutinib in this disease VJHemOnc – Video Journal of Hematology & HemOnc 2:31 1 year ago 729 Скачать Далее
